Prevail Therapeutics
Lynne Verselis is a seasoned professional in the field of clinical development with extensive experience in the biotechnology and pharmaceutical industries. Since January 2019, Lynne has held various roles at Prevail Therapeutics, currently serving as Director of Clinical Development. Prior to this, Lynne worked at Roche for over a decade, initially as Principal Scientist, where responsibilities included developing and validating biologic compounds, and later as Clinical Scientist, providing support for early phase clinical trials in CNS indications. Lynne's academic credentials include a Mini-MBA in Leading Biopharma Innovation from Rutgers Business School, an M.A. in Biology from Hofstra University, and a B.S. in Zoology from the University of Michigan.
This person is not in any teams
Prevail Therapeutics
Prevail Therapeutics are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders.